Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
mercredi, octobre 28
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Bone Biologics Corp
BBLG
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$0.3680
-0.009
-2.39%
Dern. MÀJ: Oct 27, 6:55 PM
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
Résultats:
Les résultats Q3 2026 ont été publiés le lun. oct. 26th, après la fermeture du marché
Bone Biologics Financials
Bone Biologics (BBLG) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Bone Biologics Q3 EPS $(0.17) Beats $(0.18) Estimate
Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.18) by 5.56 percent. This is a 54.05 percent increase over losses of $(0.37) per share from
Benzinga Newsdesk
PRO
Bone Biologics Q1 EPS $(0.43) Beats $(0.54) Estimate
Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.54) by 20.37 percent. This is a 77.6 percent increase over losses of $(1.92) per share from the
Benzinga Newsdesk
PRO
Bone Biologics Q2 EPS $(1.33) Misses $(0.58) Estimate
Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(1.33) per share which missed the analyst consensus estimate of $(0.58) by 129.31 percent. This is a 66.92 percent increase over losses of $(4.02) per share from
Benzinga Newsdesk
PRO
Bone Biologics Q1 EPS $(0.32) Beats $(0.48) Estimate
Bone Biologics (NASDAQ:BBLG) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.48) by 33.33 percent. This is a 75.57 percent increase over losses of $(1.31) per share from
Benzinga Newsdesk
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September
Avi Kapoor
Nasdaq Surges 1%; Meta Posts Upbeat Earnings
Avi Kapoor
